Homegrown drug major Cipla is in advance stage talks to acquire Hetero Drugs' US business, which is run under the Camber Pharmaceuticals brand.
first published: Sep 3, 2015 09:59 pm
A collection of the most-viewed Moneycontrol videos.
The Lawyer Renting in one of Mumbai’s most green societies | The Tenant
Live: Nifty extends gain for the third day, up nearly 2% this week | Closing Bell | 4K
From renewables to AI and SMEs: Madhusudan Kela on where he senses opportunity now
Will The Pre-Diwali Nifty Rally Rage On Amid Weak Global Cues? RIL Q2 in Focus | Opening Bell Live
